JP2007512237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512237A5 JP2007512237A5 JP2006536948A JP2006536948A JP2007512237A5 JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5 JP 2006536948 A JP2006536948 A JP 2006536948A JP 2006536948 A JP2006536948 A JP 2006536948A JP 2007512237 A5 JP2007512237 A5 JP 2007512237A5
- Authority
- JP
- Japan
- Prior art keywords
- ibandronate sodium
- ray
- crystalline form
- reflection
- sodium crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60402604P | 2004-08-23 | 2004-08-23 | |
| US69086705P | 2005-06-16 | 2005-06-16 | |
| PCT/US2005/030500 WO2006024024A2 (en) | 2004-08-23 | 2005-08-23 | Solid and crystalline ibandronate sodium and processes for preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007512237A JP2007512237A (ja) | 2007-05-17 |
| JP2007512237A5 true JP2007512237A5 (enExample) | 2008-02-14 |
| JP4559431B2 JP4559431B2 (ja) | 2010-10-06 |
Family
ID=35968334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006536948A Expired - Lifetime JP4559431B2 (ja) | 2004-08-23 | 2005-08-23 | 固体及び結晶イバンドロネートナトリウム及びその調製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7563918B2 (enExample) |
| EP (2) | EP1930011B1 (enExample) |
| JP (1) | JP4559431B2 (enExample) |
| KR (2) | KR20090120011A (enExample) |
| CN (1) | CN101022812A (enExample) |
| AT (2) | ATE520406T1 (enExample) |
| CA (1) | CA2576659A1 (enExample) |
| DE (2) | DE602005025977D1 (enExample) |
| ES (1) | ES2358269T3 (enExample) |
| IL (1) | IL181298A (enExample) |
| PT (2) | PT1930011E (enExample) |
| WO (1) | WO2006024024A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE044822T2 (hu) | 2003-09-12 | 2019-11-28 | Amgen Inc | Cinakalcet HCl gyors feloldódású készítménye |
| AU2006210008B2 (en) * | 2005-02-01 | 2009-10-08 | F. Hoffmann-La Roche Ag | Ibandronate polymorph B |
| CA2594802C (en) * | 2005-02-01 | 2012-11-27 | Uwe Eiermann | Ibandronate polymorph a |
| WO2007074475A2 (en) * | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
| EP2046342A4 (en) * | 2006-07-28 | 2011-05-04 | Reddys Lab Ltd Dr | CRYSTALLINE FORM WITH IBANDRONIC ACID AND PROCESS FOR PREPARING THE SAME |
| JP2009516004A (ja) * | 2006-11-16 | 2009-04-16 | テバ ファーマシューティカル インダストリーズ リミティド | イバンドロン酸ナトリウムの結晶形態 |
| CA2570949A1 (en) * | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| MX2009010850A (es) | 2007-04-11 | 2009-11-02 | Hoffmann La Roche | Sintesis de ibandronato en multiples etapas. |
| WO2008131160A1 (en) * | 2007-04-19 | 2008-10-30 | Dr. Reddy's Laboratories Ltd. | Ibandronate sodium polymorphs |
| US20090042839A1 (en) * | 2007-08-09 | 2009-02-12 | Sharon Avhar-Maydan | Crystalline forms of ibandronate sodium |
| WO2009053445A2 (en) * | 2007-10-26 | 2009-04-30 | Chemo Ibérica, S.A. | Polymorphic forms of ibandronate sodium and processes for preparation thereof |
| EP2128166A1 (en) | 2008-05-20 | 2009-12-02 | Chemo Ibérica, S.A. | Polymorphic forms of Ibandronate sodium and processes for preparation thereof |
| US20090118239A1 (en) * | 2007-11-05 | 2009-05-07 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of ibandronate disodium |
| EP2180003A1 (en) | 2008-10-21 | 2010-04-28 | Zentiva, k.s. | Preparation of ibandronate trisodium |
| SG173619A1 (en) | 2009-02-13 | 2011-09-29 | Boehringer Ingelheim Int | Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof |
| US9192316B2 (en) | 2009-05-15 | 2015-11-24 | Nox Medical | Systems and methods using flexible capacitive electrodes for measuring biosignals |
| WO2011016738A1 (en) | 2009-08-05 | 2011-02-10 | Zaklady Farmaceutyczne Polpharma Sa | A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate |
| EA032868B1 (ru) | 2010-01-27 | 2019-07-31 | Вайв Хелткер Компани | Комбинация для лечения вич-инфекции |
| CA2833111C (en) | 2010-06-25 | 2018-08-21 | Kormakur Hlini Hermannsson | Biometric belt connector |
| JP6121421B2 (ja) | 2010-09-03 | 2017-04-26 | バルネバ オーストリア ジーエムビーエイチ | Ｃ．ディフィシルの毒素ａおよび毒素ｂタンパク質の単離ポリペプチドならびにその使用 |
| UY33937A (es) | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina |
| WO2013179305A1 (en) * | 2012-06-01 | 2013-12-05 | Hetero Research Foundation | Ibandronate sodium solid dispersion |
| WO2014170909A2 (en) | 2013-04-01 | 2014-10-23 | Hetero Research Foundation | Process for pomalidomide |
| EP3065638B1 (en) | 2013-11-06 | 2024-01-10 | Nox Medical ehf. | Method, apparatus, and system for measuring respiratory effort |
| SG10202012791TA (en) | 2013-11-15 | 2021-01-28 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| EP3500155B1 (en) | 2016-08-19 | 2024-10-02 | Nox Medical | Method, system, and computer program for measuring respiratory effort of a subject |
| EP3629893A1 (en) | 2017-06-02 | 2020-04-08 | Nox Medical ehf. | Coherence-based method, apparatus, and system for identifying corresponding signals of a physiological study |
| EP3678543A1 (en) | 2017-09-08 | 2020-07-15 | Nox Medical | System and method for non-invasively determining an internal component of respiratory effort |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| JP2639721B2 (ja) | 1988-12-27 | 1997-08-13 | 富士重工業株式会社 | 内燃機関の燃焼室 |
| US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
| DE19637890A1 (de) * | 1996-09-17 | 1998-03-19 | Max Planck Gesellschaft | Biphosphonat-Liposomen |
| DE19828450A1 (de) * | 1998-06-26 | 1999-12-30 | Hassan Jomaa | Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien |
| EP0998933A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| CN1202828C (zh) * | 1999-05-21 | 2005-05-25 | 诺瓦提斯公司 | 二膦酸在制备抑制或逆转血管发生的药物中的用途 |
| US6677320B2 (en) * | 2000-01-20 | 2004-01-13 | Hoffmann-La Roches Inc. | Parenteral bisphosphonate composition with improved local tolerance |
| ES2254410T3 (es) * | 2000-05-05 | 2006-06-16 | F. Hoffmann-La Roche Ag | Composicion farmaceutica como gel para administracion subcutanea que comprende acidos bisfosfonicos o sus sales. |
| ES2247123T7 (es) * | 2000-06-20 | 2013-03-01 | Novartis Ag | Método para administrar bisfosfonatos |
| GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| MXPA02001219A (es) * | 2001-02-01 | 2005-06-06 | Riderway Corp | Composicion farmaceutica liquida para el tratamiento de enfermedades oseas. |
| ITMI20020908A1 (it) | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
| PT1880744E (pt) * | 2002-05-10 | 2015-02-13 | Hoffmann La Roche | Ácidos bisfosfónicos para o tratamento e a prevenção da osteoporose |
| US20050287135A1 (en) * | 2002-05-17 | 2005-12-29 | Wyeth | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| PL212072B1 (pl) * | 2002-12-20 | 2012-08-31 | Hoffmann La Roche | Tabletka zawierająca jako substancję czynną do 250 mg kwasu ibandronowego oraz sposób jej wytwarzania |
| EP2206717B1 (en) * | 2003-12-23 | 2013-03-27 | Alchymars S.p.A. | A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof |
| WO2006002348A2 (en) * | 2004-06-23 | 2006-01-05 | Teva Pharmaceutical Industies Ltd. | Solid and crystalline ibandronic acid |
| AU2006210008B2 (en) | 2005-02-01 | 2009-10-08 | F. Hoffmann-La Roche Ag | Ibandronate polymorph B |
| CA2594802C (en) | 2005-02-01 | 2012-11-27 | Uwe Eiermann | Ibandronate polymorph a |
| WO2007074475A2 (en) | 2005-12-27 | 2007-07-05 | Natco Pharma Limited | Novel polymorphic forms of ibandronate |
-
2005
- 2005-08-23 AT AT08002626T patent/ATE520406T1/de not_active IP Right Cessation
- 2005-08-23 WO PCT/US2005/030500 patent/WO2006024024A2/en not_active Ceased
- 2005-08-23 CA CA002576659A patent/CA2576659A1/en not_active Abandoned
- 2005-08-23 PT PT08002626T patent/PT1930011E/pt unknown
- 2005-08-23 KR KR1020097022363A patent/KR20090120011A/ko not_active Ceased
- 2005-08-23 KR KR1020077005922A patent/KR20070043043A/ko not_active Ceased
- 2005-08-23 PT PT05791142T patent/PT1713489E/pt unknown
- 2005-08-23 AT AT05791142T patent/ATE495747T1/de not_active IP Right Cessation
- 2005-08-23 DE DE602005025977T patent/DE602005025977D1/de not_active Expired - Lifetime
- 2005-08-23 EP EP08002626A patent/EP1930011B1/en not_active Expired - Lifetime
- 2005-08-23 ES ES05791142T patent/ES2358269T3/es not_active Expired - Lifetime
- 2005-08-23 CN CNA2005800285039A patent/CN101022812A/zh active Pending
- 2005-08-23 JP JP2006536948A patent/JP4559431B2/ja not_active Expired - Lifetime
- 2005-08-23 EP EP05791142A patent/EP1713489B1/en not_active Revoked
- 2005-08-23 DE DE202005021414U patent/DE202005021414U1/de not_active Expired - Lifetime
-
2006
- 2006-12-22 US US11/644,568 patent/US7563918B2/en not_active Expired - Fee Related
-
2007
- 2007-02-13 IL IL181298A patent/IL181298A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007512237A5 (enExample) | ||
| JP2007302683A5 (enExample) | ||
| FI3470063T3 (fi) | Lääkekoostumuksia cftr-välitteisten sairauksien hoitoon | |
| JP2009235100A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| JP2014005302A5 (enExample) | ||
| JP2013545785A5 (enExample) | ||
| HRP20171175T1 (hr) | Novi triciklički spojevi | |
| JP2023002516A5 (enExample) | ||
| FI2629097T1 (fi) | Nrf2-seulontatestejä ja niihin liittyviä menetelmiä ja koostumuksia | |
| HRP20140666T1 (hr) | Kristalni oblici derivata 2-tiazolil-4-kinolinil-oksi, snažnog hcv-inhibitora | |
| JP2013509429A5 (enExample) | ||
| JP2011506330A5 (enExample) | ||
| JP2014523445A5 (enExample) | ||
| HRP20150584T1 (hr) | Soli i polimorfi tetraciklinskog spoja | |
| JP2011500621A5 (enExample) | ||
| HRP20160808T4 (hr) | Kristalni paptidi epoksiketona kao inhibitori proteaze i sinteza ketoepoksidnih aminokiselina | |
| HRP20140004T1 (hr) | Novi spojevi 951: bifeniloksipropanska kiselina kao crth2 modulator i intermedijeri | |
| JP2014506907A5 (enExample) | ||
| NZ592383A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
| PH12013501727A1 (en) | Heteroaryl derivatives as alpha7 nachr modulators | |
| HRP20151338T1 (hr) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze mastocita | |
| ME02480B (me) | Optimizirana sinteza čistih, nepolimorfnih, kristalnih žučnih kiselina sa određenom veličinom čestica |